Published Paper Details:

ABSTRACT: Background: Epilepsy is a chronic neurological condition that profoundly affects patient's quality of life (QOL) due to recurrent seizures, cognitive deficits, psychosocial stigma, and adverse effects of antiepileptic medications. Pharmacists, as accessible healthcare providers, are increasingly involved in patient education, medication management, and adherence support, which may positively influence QOL outcomes. Objective: This systematic review aims to examine the effectiveness of pharmacist interventions in improving the quality of life of individuals living with epilepsy. Methods: A thorough literature search was conducted in PubMed, Scopus, Google Scholar, PsycINFO, MEDLINE, and Web of Science for studies published between July 2015 and July 2025. Eligible studies assessed pharmacist interventions such as patient counselling, educational programs, adherence monitoring, and pharmaceutical care and their impact on QOL in epilepsy patients. Data were extracted on study characteristics, intervention strategies, outcome measures, and key results. Results: Evidence from multiple studies demonstrates that pharmacist interventions enhance medication adherence, reduce treatment-related adverse effects, and improve health-related quality of life (HRQOL) in epilepsy patients. Structured counselling, educational support, and adherence-focused programs were consistently associated with better QOL outcomes across diverse populations and clinical settings. Conclusion: Pharmacist interventions are effective in improving the quality of life of patients with epilepsy. Incorporating pharmacists into multidisciplinary care teams is recommended to optimize clinical outcomes and patient wellbeing.